Romanelli, Margherita
 Distribuzione geografica
Continente #
NA - Nord America 268
EU - Europa 181
AS - Asia 23
AF - Africa 6
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 485
Nazione #
US - Stati Uniti d'America 268
IT - Italia 66
SE - Svezia 58
IE - Irlanda 22
DE - Germania 14
SG - Singapore 10
CI - Costa d'Avorio 6
HK - Hong Kong 6
GB - Regno Unito 5
CN - Cina 4
BR - Brasile 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
FR - Francia 2
IN - India 2
NZ - Nuova Zelanda 2
RO - Romania 2
RU - Federazione Russa 2
AT - Austria 1
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
Totale 485
Città #
Chandler 111
Dublin 22
Ashburn 17
Milan 16
New York 16
Boston 12
Princeton 12
Bremen 10
Abidjan 6
Feasterville Trevose 5
Hong Kong 5
Rome 5
London 4
Wilmington 4
Boydton 3
Cosenza 3
Helsinki 3
Monza 3
Ansbach 2
Auckland 2
Beijing 2
Brno 2
Comelico Superiore 2
Guarulhos 2
Los Angeles 2
Mountain View 2
Ann Arbor 1
Bern 1
Brdo 1
Brussels 1
Catania 1
Central 1
Chiswick 1
Cittadella 1
Colleferro 1
Fiumicino 1
Florence 1
Hunedoara 1
Latina 1
Leawood 1
Marseille 1
Messina 1
Monmouth Junction 1
Naples 1
Nashville 1
Paris 1
Pune 1
Redwood City 1
Rimini 1
San Francisco 1
San Mateo 1
Scarsdale 1
Seoul 1
Torino 1
Vicenza 1
Vienna 1
Washington 1
Totale 304
Nome #
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 98
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 49
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 44
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 40
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 35
Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience 34
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 34
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light 32
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 31
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 28
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 24
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 21
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 9
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 9
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 9
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 6
Totale 503
Categoria #
all - tutte 3.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 8 0 1 3 0
2021/202299 27 0 9 1 4 0 0 6 1 1 24 26
2022/2023253 28 33 15 38 20 32 9 28 33 3 9 5
2023/2024139 5 31 16 22 14 25 10 5 3 8 0 0
Totale 503